Main Article Content
Background. The purpose of the study is to determine the serum level of N-terminal propeptide of type I procollagen (PINP) in healthy men and women of various ages. Materials and methods. The study included 1,568 individuals (1,422 females and 146 males, aged 20-89 years (mean age 60.36 ± 13.68 yrs). All patients were divided into 7 groups, by decades and according to the gerontological age classification: young age – 20–44 yrs, middle age 45–59 yrs, elderly 60–74 yrs, and old 75-89 yrs. During the study, we examined the effect of such demographic characteristics, as age and gender, on serum PINP level, using the electrochemiluminescence immunoassay ECLIA on the cobas e 411 analyzer. Results. We have detected no significant effect of age on the serum variability of PINP in females (F = 1.453, p = 0.19). However, we observed a significant decrease of PINP level in the female age groups of 40–49 yrs (47.74 ± 21.31, p = 0.02), 60–69 yrs (49.76 ± 25.75, p = 0.03), 70–79 yrs (50.49 ± 26.71, p = 0.04), compared with the age group of 20–29 yrs (58.67 ± 27.46). The regression analysis revealed a significant decrease of PINP level with age in young women and men (20–44 years). When comparing serum PINP level in the oldest age group (80-89 years), we detected its increase in women (55.20 ± 28.38 ng/ml), compared with the 70–79 years group (50.49 ± 26.71 ng/ml), and its decrease in men (54.87 ± 28.24 and 39.16 ± 12.46 ng/ml, respectively). In men, we revealed significant effect of age on the serum variability of PINP (F = 3,077, p = 0.007). Conclusions. The regression analysis showed a significant decrease in PINP level with age in men and women of 20-44 years. In men, we detected a significant effect of age on the variability of serum PINP level. A comparison of serum PINP levels in the oldest age group of 80-89 revealed its increase in women, compared to the 70–79 age group, and decrease in men. The obtained results may be used as reference values for PINP level in serum among representatives of the Ukrainian population of various ages and sexes.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Shetty S, Kapoor N, Bondu JD, Thomas N, Paul TV. Bone turnover markers: Emerging tool in the management of osteoporosis. Indian J Endocrinol Metab. 2016;20(6):846–852. https://doi.org/10.4103/2230-8210.192914.
Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005;26(4):97–122.
Roodman GD, Guise TA. Bone and Cancer. In: Burr DB, Allen MR, editors. Basic and Applied Bone Biology. 2th ed. USA: Academic Press; 2019. 411-423 pp. https://doi.org/10.1016/B978-0-12-813259-3.00022-1.
Szulc P, Naylor K, Hoyle NR, Eastell R, Leary ET; National Bone Health Alliance Bone Turnover Marker Project. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporos Int. 2017;28(9):2541–2556. https://doi.org/10.1007/s00198-017-4082-4.
Coates P. Bone turnover markers. Aust Fam Physician. 2013;42(5):285–287.
Povoroznyuk VV, Balatska NI. Role of bone tissue turnover markers in diagnosis of osteoporosis. Mystetstvo likuvannya. 2013;2–3:98–99. (in Ukrainian).
Povoroznyuk VV. Osteoporosis and biochemical bone turnover markers. Laboratory diagnosis. 2002;1:53–61. (in Ukrainian).
Redmond J, Fulford AJ, Jarjou L, Zhou B, Prentice A, Schoenmakers I. Diurnal Rhythms of Bone Turnover Markers in Three Ethnic Groups. J Clin Endocrinol Metab. 2016;101(8):3222–3230. https://doi.org/10.1210/jc.2016-1183.
Povoroznyuk VV, Grygorieva N.V. Menopause and osteoporosis. Mystetstvo likuvannya. 2005;3:25–30. (in Ukrainian).
State Statistics Service of Ukraine. Fertility, mortality, and average life expectancy tables for 2018. Kyiv; 2019. 66 p.
Eurostat. Life expectancy at birth in the EU: men vs. women. 2017. Available from: https://ec.europa.eu/eurostat/web/products-eurostat-news/-/DDN-20190725-1
Vasikaran S, Eastell R, Bruyère O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391–420. https://doi.org/10.1007/s00198-010-1501-1.
Garnero P, Szulc P. Assessment of Bone Turnover in Men Using Biochemical Markers. In: Orwoll E, Bilezikian J, Vanderschueren D, editors. Osteoporosis in Men. 2nd ed. Academic Press; 2009. 25-40 pp. https://doi.org/10.1016/B978-0-12-374602-3.00003-1.
Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5(11):908–923. https://doi.org/10.1016/s2213-8587(17)30184-5.
Kitareewan W, Boonhong J, Janchai S, Aksaranugraha S. Effects of the treadmill walking exercise on the biochemical bone markers. J Med Assoc Thai. 2011;94 Suppl 5:S10–S16.
Aaron JE, Makins NB, Sagreiya K. The microanatomy of trabecular bone loss in normal aging men and women. Clin Orthop Relat Res. 1987;(215):260–271.
Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003;88(10):4623–4632. https://doi.org/10.1210/jc.2003-030358.
Ferreira A, Alho I, Casimiro S, Costa L. Bone remodeling markers and bone metastases: From cancer research to clinical implications. Bonekey Rep. 2015;4:668. https://doi.org/10.1038/bonekey.2015.35.
Weiler R, Keen R, Wolman R. Changes in bone turnover markers during the close season in elite football (soccer) players. J Sci Med Sport. 2012;15(3):255–258. https://doi.org/10.1016/j.jsams.2011.09.004.